Vaccines and Other Medical Materials Updated During January 2021, From Newest to Oldest

Page 1 of 9 1 2 3 4 5 … » Last Page »

HEPLISAV-B (Hepatitis B Vaccine (Recombinant) Adjuvanted)

HEPLISAV-B is indicated for prevention of infection caused by all known subtypes of hepatitis B virus. HEPLISAV-B is approved for use in adults 18 years of age and older. HEPLISAV-B is…

Dynavax Technologies Corporation29 January 2021

Reserpine

Image description image description image description.

BLUEBAY SHANDONG CO.,LTD29 January 2021

Betadex Sulfobutyl Ether Sodium

Image description image description.

BLUEBAY SHANDONG CO.,LTD27 January 2021

Pimobendan

Pimobendan.

Spectrum Laboratory Products, Inc.26 January 2021

Page 1 of 9 1 2 3 4 5 … » Last Page »

FDA Medwatch

Hospira Issues A Voluntary Nationwide Recall for One Lot of Sterile Water for Injection, USP, Due to the Potential Presence of Visible Particulate
Mon, 03 May 2021. Hospira, Inc., a Pfizer company, is voluntarily recalling lot DN9185 of Sterile Water for Injection, USP, 100 mL Single Dose Glass Fliptop Vial, to the hospital/institution level due to a confirmed customer report for a single vial with a visible…
Hospira Issues A Voluntary Nationwide Recall for One Lot of 0.5% Bupivacaine Hydrochloride Injection, USP and One Lot of 1% Lidocaine HCl Injection, USP Due to Mislabeling
Mon, 03 May 2021. Hospira, Inc., a Pfizer company, is voluntarily recalling lot EG6023 of 0.5% Bupivacaine Hydrochloride Injection, USP 30 mL and lot EG8933 of 1% Lidocaine HCl Injection, USP 30 mL, to the hospital/institution level due to mislabeling whereby a…

DrugInserts.com

Information Sections

RSS Feeds

About

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.